Ken d'Entremont is the founder of Medexus Pharmaceuticals. Medexus Pharmaceuticals has raised $85M in total funding. Latest round: Growth.
Ken d'Entremont is the founder, president, and CEO of Medexus Pharmaceuticals. He established Medexus as a private entity and led its transition to a public company on the TSX Venture Exchange. He built the company by consolidating and acquiring specialty pharma companies, achieving over $100 million in revenue.
Full founder directory · Investor directory · Company funding database · Fundraising library